Acorda Therapeutics, Inc. Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31)
Acorda Therapeutics, Inc. reported Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) of $16.20 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense · last filed 2012-02-28
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $1.10M, a 37.50% increase year-over-year.
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $13.70M, a 1857.14% increase year-over-year.
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2010-12-31 was $800.00K.
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $700.00K.
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2011 was $16.20M, a 478.57% increase from fiscal 2010.
- Acorda Therapeutics, Inc. finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for fiscal 2010 was $2.80M.
| Period end | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 3 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 6 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 9 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $14.80M derived: sum of 2 quarters · filed 2012-02-28 | $16.20M 10-K · filed 2012-02-28 | |
| 2011-09-30 | $13.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $15.10M 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | $1.40M 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.50M derived: sum of 2 quarters · filed 2012-02-28 | $2.80M 10-K · filed 2012-02-28 | |
| 2010-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $2.00M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $1.30M 10-Q · filed 2011-08-08 |